Torsten Böhmer Selected Research

Onyvax-P

10/2005

Technology evaluation: Onyvax-P, Onyvax.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Torsten Böhmer Research Topics

Disease

3	Neoplasms (Cancer) 01/2008 - 11/2002
3	Prostatic Neoplasms (Prostate Cancer) 01/2008 - 10/2005
2	Breast Neoplasms (Breast Cancer) 12/2002 - 11/2002
2	Carcinoma (Carcinomatosis) 12/2002 - 11/2002
1	Disease Progression 01/2008
1	Lymphatic Metastasis 11/2002
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2002

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 01/2008 - 10/2005
2	Trastuzumab (Herceptin)FDA Link 12/2002 - 11/2002
2	Monoclonal AntibodiesIBA 12/2002 - 11/2002
1	Cytostatic AgentsIBA 01/2008
1	AntigensIBA 01/2008
1	Hormones (Hormone)IBA 01/2008
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2008
1	prostatic acid phosphataseIBA 01/2008
1	PROSTVACIBA 04/2007
1	CD58 Antigens (LFA-3)IBA 04/2007
1	Onyvax-PIBA 10/2005
1	ParaffinIBA 12/2002
1	Proteins (Proteins, Gene)FDA Link 11/2002
1	Oncogene Proteins (Oncogene Protein)IBA 11/2002
1	ErbB-2 ReceptorIBA 11/2002

Therapy/Procedure

3	Therapeutics 01/2008 - 11/2002
1	Drug Therapy (Chemotherapy) 01/2008
1	Immunotherapy 01/2008
1	Radiotherapy 01/2008
1	Cystectomy 12/2002